DÜSSELDORF, Germany, Sept. 3, 2025 /PRNewswire/ -- LenioBio GmbH today announced a strategic partnership with AffinityAI, a Danish start-up pioneering AI-driven protein design. This collaboration ...
Advances in mRNA design continue to shape the next generation of therapeutic development. Yet, achieving strong and sustained protein expression remains a persistent challenge across platforms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results